Novo`s Etavopivat Meets Both Endpoints in Sickle Cell Disease
20 Apr 2026 //
GLOBENEWSWIRE
Forma`s Investigational Once-Daily Etavopivat Shows Improvement in SCD
11 Dec 2021 //
BUSINESSWIRE
Forma Therapeutics Announces Four Presentations on Etavopivat ASH
04 Nov 2021 //
BUSINESSWIRE

Market Place
Sourcing Support